IPO Grey Market Trends: Nephrocare Health vs Park Medi World Day 2
Park Medi World and Nephrocare Health IPOs remain undersubscribed on Day 2, but grey market trends indicate potential listing gains of 7% and 4% respectively. Check IPO details, subscription dates, and listing outlook.
IPO Grey Market Trends: Nephrocare Health vs Park Medi World Day 2
The IPOs of Park Medi World Ltd. and Nephrocare Health Services Ltd., which were open for subscription starting from December 10, 2025, have met with a soft reaction from the investors with both IPOs remaining undersubscribed even on the second day. The grey market premium (GMP) is a little at the investor's end but is indicating good listing gains, which are approximately Park Medi World at 7% and Nephrocare Health at 4%.
The below-given trends provide the latest updates regarding these healthcare IPOs:
Park Medi World IPO GMP & Listing Outlook
On December 11, 2025, the grey market premium for Park Medi World IPO was at Rs 12 per share which means a price of Rs 174 per share at listing thus, showing a premium of 7.41% over the IPO’s upper price band of Rs 162.
Details of the IPO:
- Total Issue Size: Rs 920 crore
- New issue: 4.75 crore shares valued at Rs 770 crore
- Offer for Sale (OFS): 93 lakh shares worth Rs 150 crore
- Price Band: Rs 154 – Rs 162 per share
- Minimum lot: 92 shares (approx. Rs 14,904)
Park Medi World is the biggest private hospital chain in North India with a bed capacity of 2000 providing investors with access to a health-provider in the particular market which is growing.
Nephrocare Health Services IPO GMP & Listing Outlook
As for Nephrocare Health, the GMP of Rs 20 per share was on December 11 suggesting a potential listing price of Rs 480, a 4.35% premium over the IPO’s upper price band of Rs 460.
About the IPO:
- Total Issue Size: Rs 871.05 crore
- Fresh Issue: 77 lakh shares worth Rs 353.4 crore
- Offer for Sale (OFS): 1.13 crore shares, valued at Rs 517.64 crore
- Price Band: Rs 438 – Rs 460 per share
- Minimum Lot: 32 shares (approx. Rs 14,720 per application)
Nephrocare Health Services is engaged in dialysis services in India and some selected international markets, hence has strategically placed itself in the fast-growing healthcare segment.
Important IPO Dates
- Subscription Window: December 10 - 12, 2025
- Share Allotment Status: Anticipated on December 15, 2025
- Tentative Listing Date: December 17, 2025, on BSE and NSE
Although the response of investors has not been great the premiums in the grey market indicate that there might be good short-term listing gains so the IPOs become interesting for both retail and institutional investors to consider.
